ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Grade Poloxamers Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-33P16869
Home | Market Reports | Business & Industrial| Chemicals Industry| Plastics & Polymers
Global Pharmaceutical Grade Poloxamers Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Grade Poloxamers Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-33P16869
Report
November 2025
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BASF AG
CRODA
Syensqo
Nanjing Well Pharmaceutical
Hubei Hengshuo Chemical
CD Formulation

Pharmaceutical Grade Poloxamers Market

The global Pharmaceutical Grade Poloxamers market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
From a downstream perspective, Injectable Formulation accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Grade Poloxamers leading manufacturers including BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation, etc., dominate supply; the top five capture approximately % of global revenue, with BASF leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Grade Poloxamers market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceutical Grade Poloxamers Market Report

Report Metric Details
Report Name Pharmaceutical Grade Poloxamers Market
Segment by Type
  • Poloxamer 188
  • Poloxamer 124
  • Poloxamer 407
  • Poloxamer 338
  • Others
Segment by Application
  • Injectable Formulation
  • Oral Formulation
  • Topical Formulation
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceutical Grade Poloxamers study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceutical Grade Poloxamers Market report?

Ans: The main players in the Pharmaceutical Grade Poloxamers Market are BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, CD Formulation

What are the Application segmentation covered in the Pharmaceutical Grade Poloxamers Market report?

Ans: The Applications covered in the Pharmaceutical Grade Poloxamers Market report are Injectable Formulation, Oral Formulation, Topical Formulation

What are the Type segmentation covered in the Pharmaceutical Grade Poloxamers Market report?

Ans: The Types covered in the Pharmaceutical Grade Poloxamers Market report are Poloxamer 188, Poloxamer 124, Poloxamer 407, Poloxamer 338, Others

1 Study Coverage
1.1 Introduction to Pharmaceutical Grade Poloxamers: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Grade Poloxamers Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Poloxamer 188
1.2.3 Poloxamer 124
1.2.4 Poloxamer 407
1.2.5 Poloxamer 338
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Grade Poloxamers Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Injectable Formulation
1.3.3 Oral Formulation
1.3.4 Topical Formulation
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Grade Poloxamers Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Grade Poloxamers Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceutical Grade Poloxamers Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceutical Grade Poloxamers Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pharmaceutical Grade Poloxamers Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pharmaceutical Grade Poloxamers Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Poloxamer 188 Market Size by Manufacturers
3.5.2 Poloxamer 124 Market Size by Manufacturers
3.5.3 Poloxamer 407 Market Size by Manufacturers
3.5.4 Poloxamer 338 Market Size by Manufacturers
3.5.5 Others Market Size by Manufacturers
3.6 Global Pharmaceutical Grade Poloxamers Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Grade Poloxamers Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Grade Poloxamers Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Grade Poloxamers Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pharmaceutical Grade Poloxamers Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pharmaceutical Grade Poloxamers Sales and Revenue by Type (2020-2031)
6.4 North America Pharmaceutical Grade Poloxamers Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Grade Poloxamers Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pharmaceutical Grade Poloxamers Sales and Revenue by Type (2020-2031)
7.4 Europe Pharmaceutical Grade Poloxamers Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Grade Poloxamers Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Grade Poloxamers Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Grade Poloxamers Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pharmaceutical Grade Poloxamers Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pharmaceutical Grade Poloxamers Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pharmaceutical Grade Poloxamers Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Grade Poloxamers Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Grade Poloxamers Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Grade Poloxamers Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Grade Poloxamers Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BASF
11.1.1 BASF Corporation Information
11.1.2 BASF Business Overview
11.1.3 BASF Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.1.4 BASF Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BASF Pharmaceutical Grade Poloxamers Sales by Product in 2024
11.1.6 BASF Pharmaceutical Grade Poloxamers Sales by Application in 2024
11.1.7 BASF Pharmaceutical Grade Poloxamers Sales by Geographic Area in 2024
11.1.8 BASF Pharmaceutical Grade Poloxamers SWOT Analysis
11.1.9 BASF Recent Developments
11.2 Croda
11.2.1 Croda Corporation Information
11.2.2 Croda Business Overview
11.2.3 Croda Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.2.4 Croda Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Croda Pharmaceutical Grade Poloxamers Sales by Product in 2024
11.2.6 Croda Pharmaceutical Grade Poloxamers Sales by Application in 2024
11.2.7 Croda Pharmaceutical Grade Poloxamers Sales by Geographic Area in 2024
11.2.8 Croda Pharmaceutical Grade Poloxamers SWOT Analysis
11.2.9 Croda Recent Developments
11.3 Syensqo
11.3.1 Syensqo Corporation Information
11.3.2 Syensqo Business Overview
11.3.3 Syensqo Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.3.4 Syensqo Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Syensqo Pharmaceutical Grade Poloxamers Sales by Product in 2024
11.3.6 Syensqo Pharmaceutical Grade Poloxamers Sales by Application in 2024
11.3.7 Syensqo Pharmaceutical Grade Poloxamers Sales by Geographic Area in 2024
11.3.8 Syensqo Pharmaceutical Grade Poloxamers SWOT Analysis
11.3.9 Syensqo Recent Developments
11.4 Nanjing Well Pharmaceutical
11.4.1 Nanjing Well Pharmaceutical Corporation Information
11.4.2 Nanjing Well Pharmaceutical Business Overview
11.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.4.4 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales by Product in 2024
11.4.6 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales by Application in 2024
11.4.7 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales by Geographic Area in 2024
11.4.8 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers SWOT Analysis
11.4.9 Nanjing Well Pharmaceutical Recent Developments
11.5 Hubei Hengshuo Chemical
11.5.1 Hubei Hengshuo Chemical Corporation Information
11.5.2 Hubei Hengshuo Chemical Business Overview
11.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.5.4 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales by Product in 2024
11.5.6 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales by Application in 2024
11.5.7 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales by Geographic Area in 2024
11.5.8 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers SWOT Analysis
11.5.9 Hubei Hengshuo Chemical Recent Developments
11.6 CD Formulation
11.6.1 CD Formulation Corporation Information
11.6.2 CD Formulation Business Overview
11.6.3 CD Formulation Pharmaceutical Grade Poloxamers Product Models, Descriptions and Specifications
11.6.4 CD Formulation Pharmaceutical Grade Poloxamers Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 CD Formulation Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pharmaceutical Grade Poloxamers Industry Chain
12.2 Pharmaceutical Grade Poloxamers Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pharmaceutical Grade Poloxamers Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pharmaceutical Grade Poloxamers Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Grade Poloxamers Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Grade Poloxamers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
BASF AG
CRODA
Syensqo
Nanjing Well Pharmaceutical
Hubei Hengshuo Chemical
CD Formulation
List of Tables
 Table 1. Global Pharmaceutical Grade Poloxamers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceutical Grade Poloxamers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceutical Grade Poloxamers Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceutical Grade Poloxamers Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pharmaceutical Grade Poloxamers Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Pharmaceutical Grade Poloxamers Sales by Region (2020-2025) & (Tons)
 Table 8. Global Pharmaceutical Grade Poloxamers Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pharmaceutical Grade Poloxamers Sales by Manufacturers (2020-2025) & (Tons)
 Table 11. Global Pharmaceutical Grade Poloxamers Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pharmaceutical Grade Poloxamers Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pharmaceutical Grade Poloxamers by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Poloxamers as of 2024)
 Table 16. Global Pharmaceutical Grade Poloxamers Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pharmaceutical Grade Poloxamers Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Pharmaceutical Grade Poloxamers Manufacturing Base and Headquarters
 Table 19. Global Pharmaceutical Grade Poloxamers Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pharmaceutical Grade Poloxamers Sales by Type (2020-2025) & (Tons)
 Table 23. Global Pharmaceutical Grade Poloxamers Sales by Type (2026-2031) & (Tons)
 Table 24. Global Pharmaceutical Grade Poloxamers Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceutical Grade Poloxamers Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical Grade Poloxamers ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pharmaceutical Grade Poloxamers Sales by Application (2020-2025) & (Tons)
 Table 29. Global Pharmaceutical Grade Poloxamers Sales by Application (2026-2031) & (Tons)
 Table 30. Pharmaceutical Grade Poloxamers High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pharmaceutical Grade Poloxamers Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pharmaceutical Grade Poloxamers Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pharmaceutical Grade Poloxamers ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pharmaceutical Grade Poloxamers Growth Accelerators and Market Barriers
 Table 37. North America Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pharmaceutical Grade Poloxamers Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pharmaceutical Grade Poloxamers Growth Accelerators and Market Barriers
 Table 40. Europe Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pharmaceutical Grade Poloxamers Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pharmaceutical Grade Poloxamers Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pharmaceutical Grade Poloxamers Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pharmaceutical Grade Poloxamers Investment Opportunities and Key Challenges
 Table 47. Central and South America Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pharmaceutical Grade Poloxamers Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. BASF Corporation Information
 Table 51. BASF Description and Major Businesses
 Table 52. BASF Product Models, Descriptions and Specifications
 Table 53. BASF Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. BASF Sales Value Proportion by Product in 2024
 Table 55. BASF Sales Value Proportion by Application in 2024
 Table 56. BASF Sales Value Proportion by Geographic Area in 2024
 Table 57. BASF Pharmaceutical Grade Poloxamers SWOT Analysis
 Table 58. BASF Recent Developments
 Table 59. Croda Corporation Information
 Table 60. Croda Description and Major Businesses
 Table 61. Croda Product Models, Descriptions and Specifications
 Table 62. Croda Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Croda Sales Value Proportion by Product in 2024
 Table 64. Croda Sales Value Proportion by Application in 2024
 Table 65. Croda Sales Value Proportion by Geographic Area in 2024
 Table 66. Croda Pharmaceutical Grade Poloxamers SWOT Analysis
 Table 67. Croda Recent Developments
 Table 68. Syensqo Corporation Information
 Table 69. Syensqo Description and Major Businesses
 Table 70. Syensqo Product Models, Descriptions and Specifications
 Table 71. Syensqo Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. Syensqo Sales Value Proportion by Product in 2024
 Table 73. Syensqo Sales Value Proportion by Application in 2024
 Table 74. Syensqo Sales Value Proportion by Geographic Area in 2024
 Table 75. Syensqo Pharmaceutical Grade Poloxamers SWOT Analysis
 Table 76. Syensqo Recent Developments
 Table 77. Nanjing Well Pharmaceutical Corporation Information
 Table 78. Nanjing Well Pharmaceutical Description and Major Businesses
 Table 79. Nanjing Well Pharmaceutical Product Models, Descriptions and Specifications
 Table 80. Nanjing Well Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. Nanjing Well Pharmaceutical Sales Value Proportion by Product in 2024
 Table 82. Nanjing Well Pharmaceutical Sales Value Proportion by Application in 2024
 Table 83. Nanjing Well Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 84. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers SWOT Analysis
 Table 85. Nanjing Well Pharmaceutical Recent Developments
 Table 86. Hubei Hengshuo Chemical Corporation Information
 Table 87. Hubei Hengshuo Chemical Description and Major Businesses
 Table 88. Hubei Hengshuo Chemical Product Models, Descriptions and Specifications
 Table 89. Hubei Hengshuo Chemical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Hubei Hengshuo Chemical Sales Value Proportion by Product in 2024
 Table 91. Hubei Hengshuo Chemical Sales Value Proportion by Application in 2024
 Table 92. Hubei Hengshuo Chemical Sales Value Proportion by Geographic Area in 2024
 Table 93. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers SWOT Analysis
 Table 94. Hubei Hengshuo Chemical Recent Developments
 Table 95. CD Formulation Corporation Information
 Table 96. CD Formulation Description and Major Businesses
 Table 97. CD Formulation Product Models, Descriptions and Specifications
 Table 98. CD Formulation Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. CD Formulation Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Grade Poloxamers Product Picture
 Figure 2. Global Pharmaceutical Grade Poloxamers Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Poloxamer 188 Product Picture
 Figure 4. Poloxamer 124 Product Picture
 Figure 5. Poloxamer 407 Product Picture
 Figure 6. Poloxamer 338 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Pharmaceutical Grade Poloxamers Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Injectable Formulation
 Figure 10. Oral Formulation
 Figure 11. Topical Formulation
 Figure 12. Pharmaceutical Grade Poloxamers Report Years Considered
 Figure 13. Global Pharmaceutical Grade Poloxamers Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Pharmaceutical Grade Poloxamers Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2020-2031)
 Figure 17. Global Pharmaceutical Grade Poloxamers Sales (2020-2031) & (Tons)
 Figure 18. Global Pharmaceutical Grade Poloxamers Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 19. Global Pharmaceutical Grade Poloxamers Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Pharmaceutical Grade Poloxamers Sales Volume Market Share in 2024
 Figure 21. Global Pharmaceutical Grade Poloxamers Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Poloxamer 188 Revenue Market Share by Manufacturer in 2024
 Figure 24. Poloxamer 124 Revenue Market Share by Manufacturer in 2024
 Figure 25. Poloxamer 407 Revenue Market Share by Manufacturer in 2024
 Figure 26. Poloxamer 338 Revenue Market Share by Manufacturer in 2024
 Figure 27. Others Revenue Market Share by Manufacturer in 2024
 Figure 28. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2020-2031)
 Figure 29. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2020-2031)
 Figure 30. Global Pharmaceutical Grade Poloxamers Sales Market Share by Application (2020-2031)
 Figure 31. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2020-2031)
 Figure 32. North America Pharmaceutical Grade Poloxamers Sales YoY (2020-2031) & (Tons)
 Figure 33. North America Pharmaceutical Grade Poloxamers Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. North America Top 5 Manufacturers Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) in 2024
 Figure 35. North America Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Type (2020- 2031)
 Figure 36. North America Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 37. North America Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Application (2020-2031)
 Figure 38. North America Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 39. US Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 40. Canada Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 41. Mexico Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 42. Europe Pharmaceutical Grade Poloxamers Sales YoY (2020-2031) & (Tons)
 Figure 43. Europe Pharmaceutical Grade Poloxamers Revenue YoY (2020-2031) & (US$ Million)
 Figure 44. Europe Top 5 Manufacturers Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) in 2024
 Figure 45. Europe Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Type (2020-2031)
 Figure 46. Europe Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 47. Europe Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Application (2020-2031)
 Figure 48. Europe Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 49. Germany Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 50. France Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 51. U.K. Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 52. Italy Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 53. Russia Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Pharmaceutical Grade Poloxamers Sales YoY (2020-2031) & (Tons)
 Figure 55. Asia-Pacific Pharmaceutical Grade Poloxamers Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Asia-Pacific Top 8 Manufacturers Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) in 2024
 Figure 57. Asia-Pacific Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Type (2020- 2031)
 Figure 58. Asia-Pacific Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 59. Asia-Pacific Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Application (2020-2031)
 Figure 60. Asia-Pacific Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 61. Indonesia Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 62. Japan Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 63. South Korea Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 64. China Taiwan Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 65. India Pharmaceutical Grade Poloxamers Revenue (2020-2031) & (US$ Million)
 Figure 66. Central and South America Pharmaceutical Grade Poloxamers Sales YoY (2020-2031) & (Tons)
 Figure 67. Central and South America Pharmaceutical Grade Poloxamers Revenue YoY (2020-2031) & (US$ Million)
 Figure 68. Central and South America Top 5 Manufacturers Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) in 2024
 Figure 69. Central and South America Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Type (2021-2031)
 Figure 70. Central and South America Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 71. Central and South America Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Application (2020-2031)
 Figure 72. Central and South America Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 73. Brazil Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 74. Argentina Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 75. Middle East, and Africa Pharmaceutical Grade Poloxamers Sales YoY (2020-2031) & (Tons)
 Figure 76. Middle East and Africa Pharmaceutical Grade Poloxamers Revenue YoY (2020-2031) & (US$ Million)
 Figure 77. Middle East and Africa Top 5 Manufacturers Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) in 2024
 Figure 78. Middle East and Africa Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Type (2021-2031)
 Figure 79. South America Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 80. Middle East and Africa Pharmaceutical Grade Poloxamers Sales Volume (Tons) by Application (2020-2031)
 Figure 81. Middle East and Africa Pharmaceutical Grade Poloxamers Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 82. GCC Countries Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 83. Turkey Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 84. Egypt Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 85. South Africa Pharmaceutical Grade Poloxamers Revenue (2020-2025) & (US$ Million)
 Figure 86. Pharmaceutical Grade Poloxamers Industry Chain Mapping
 Figure 87. Regional Pharmaceutical Grade Poloxamers Manufacturing Base Distribution (%)
 Figure 88. Global Pharmaceutical Grade Poloxamers Production Market Share by Region (2020-2031)
 Figure 89. Pharmaceutical Grade Poloxamers Production Process
 Figure 90. Regional Pharmaceutical Grade Poloxamers Production Cost Structure
 Figure 91. Channels of Distribution (Direct Vs Distribution)
 Figure 92. Bottom-up and Top-down Approaches for This Report
 Figure 93. Data Triangulation
 Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Poloxamer 184 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poloxamer 188 Excipients Market Research Report 2024
EO PO Block Copolymers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
EO PO Copolymers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Grade Polysorbate Market Research Report 2024
Global Water Soluble Polymers for Pharmaceutical Market Research Report 2024
Pharmaceutical Grade Crospovidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Grade Polyethylene Glycol PEG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Siloxane Polymer Market Research Report 2024
Global Prefillable COP Polymer Syringes Market Research Report 2025
Global Polymer Nanoparticles PNP Formulation Development Market Research Report 2024
Global Fluoropolymer in Healthcare Market Research Report 2024
Global Pharmaceutical Grade VP VA Copolymer Market Research Report 2024
Pharmaceutical Grade Crospovidonum PVPP Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Polymer Excipients Market Research Report 2024
Global Pharmaceutical Grade Carbomers Market Insights Forecast to 2030
Global Pharmaceutical Polyethylene Glycol Market Research Report 2025
Global Nonylphenol Polyethylene Glycol Ether Market Research Report 2024
Global Medical Grade Polyolefins Market Research Report 2025
Global Pharmaceutical Grade Ethylcellulose Market Research Report 2024

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Tall Oil Modified Phenolic Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5A20121
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Engineering Plastics Core-Shell Toughening Agents Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L20106
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Maleic Anhydride-Acrylic Acid Copolymer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12I20204
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions